O&G Vivas · Gynaecological health — menstrual disorders
Dysmenorrhoea and PMDD — structured oral station (12 minutes)
FRANZCOG oral-format station on dysmenorrhoea and PMDD: the candidate classifies primary vs secondary dysmenorrhoea, names the prostaglandin pathway, defends the stepped management, and reproduces the DSM-5 PMDD criteria with the symptom-free follicular phase signature. Scored against the eight published RANZCOG oral domains.
On this page
Study tools
Target exams
Station format
4 minutes reading, 12 minutes examination, 20 marks, global scoring. The eight published RANZCOG oral domains apply to every station: history and examination; investigations and interpreting results; treatment and management; clinical knowledge; complex, urgent or unusual clinical presentations; rapport with patient, support person or colleague; respect; communication skills. You are marked on how you behave, not only what you know. [1]
Reveal the examiner script and model responsesShowHide
Opening prompt — "How do you classify this 16-year-old's dysmenorrhoea, and what is its mechanism?"
Model response — primary dysmenorrhoea and the prostaglandin pathway: [1][2]
- "This is primary dysmenorrhoea: cramping lower abdominal pain in the absence of pelvic pathology, beginning within 6-12 months of menarche, peaking in the first 24-72 hours, with a normal pelvic examination."
- "The mechanism is prostaglandin-mediated. Late-luteal progesterone withdrawal triggers endometrial arachidonic acid release; cyclo-oxygenase converts it to PGF2alpha and PGE2; PGF2alpha causes myometrial contraction and spiral-arteriole vasoconstriction, producing uterine ischaemia and pain. NSAIDs block COX."[1]
Probe 1 — "Walk me through your stepped management."
- "Step 1: an NSAID commenced at onset of menstruation — ibuprofen 400 mg three times daily with food, or naproxen 500 mg then 250 mg every 6-8 hours — plus topical heat and exercise. The Cochrane review confirms NSAIDs are more effective than placebo." [1]
- "Step 2: a combined oral contraceptive or a progestin to suppress ovulation and thin the endometrium." [2]
- "Step 3: a levonorgestrel intrauterine system for refractory primary dysmenorrhoea."
- "Step 4: investigate for a secondary cause if there is no response at 3-6 months — ACOG Committee Opinion 760."[2]
Probe 2 — "The 30-year-old with severe premenstrual mood symptoms — what are her DSM-5 PMDD criteria?"
- "Criterion A: at least five symptoms in the final week before menses, improving within a few days of onset and minimal or absent in the week postmenses." [3]
- "Criterion B (one or more required): marked affective lability; marked irritability or anger; marked depressed mood; marked anxiety or tension." [3]
- "Criterion C: additional symptoms (decreased interest, concentration difficulty, lethargy, appetite change, sleep change, feeling overwhelmed, physical symptoms) bring the total to five." [3]
- "Criterion F: confirmed by prospective daily ratings over at least two symptomatic cycles — and there must be a symptom-free follicular phase."[3]
Probe 3 — "Her symptom diary shows symptoms throughout the cycle. What does that mean?"
- "It is not PMDD — DSM-5 Criterion E requires that the disturbance is not merely an exacerbation of another psychiatric disorder. Persistent symptoms throughout the cycle point to a primary mood disorder (depression, dysthymia, generalised anxiety), and I would arrange formal psychiatric assessment before prescribing an SSRI — particularly to exclude bipolar disorder, where SSRIs can destabilise mood."[3]
Probe 4 — Communication: "She asks whether she needs to take an antidepressant every day."
- "I would say: 'For PMDD, an SSRI works whether you take it every day or only in the two weeks before your period — the luteal phase. The Cochrane review confirms both are effective. We will choose the option that fits your life and your symptoms.' That gives her the evidence and the choice."[4]
References4ShowHide
- [1]Marjoribanks J, Ayeleke RO, Farquhar C, Proctor M Nonsteroidal anti-inflammatory drugs for dysmenorrhoea. Cochrane Database Syst Rev, 2015.PMID 26224322
- [2]American College of Obstetricians and Gynecologists' Committee on Adolescent Health Care ACOG Committee Opinion No. 760: Dysmenorrhea and Endometriosis in the Adolescent. Obstet Gynecol, 2018.PMID 30461694
- [3]Hofmeister S, Bodden S Premenstrual Syndrome and Premenstrual Dysphoric Disorder. Am Fam Physician, 2016.PMID 27479626
- [4]Marjoribanks J, Brown J, O'Brien PM, Wyatt K Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst Rev, 2013.PMID 23744611